ASX - By Stock
|
BIT |
Re:
Ann: Letter to Shareholders
|
|
WelshBuffett
|
157 |
48K |
3 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
157
|
48K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
513K |
4 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
1.6K
|
513K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIOTRON CLINICAL TRIAL RESULTS WEBINAR
|
|
WelshBuffett
|
151 |
44K |
4 |
26/06/24 |
26/06/24 |
ASX - By Stock
|
151
|
44K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
235 |
67K |
11 |
21/06/24 |
21/06/24 |
ASX - By Stock
|
235
|
67K
|
11
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
115
|
33K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
235 |
67K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
235
|
67K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Locke Extension
|
|
WelshBuffett
|
275 |
138K |
2 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
275
|
138K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
513K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
1.6K
|
513K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
4 |
20/06/24 |
20/06/24 |
ASX - By Stock
|
115
|
33K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
513K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
513K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
513K |
0 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
513K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.6K |
513K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
1.6K
|
513K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
2 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
5 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives
|
|
WelshBuffett
|
115 |
33K |
6 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
115
|
33K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
1 |
19/06/24 |
19/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
The Final Countdown
|
|
WelshBuffett
|
235 |
67K |
1 |
17/06/24 |
17/06/24 |
ASX - By Stock
|
235
|
67K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
0 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
14/06/24 |
14/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
13/06/24 |
13/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
4 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
12/06/24 |
12/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
1 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
0 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
11/06/24 |
11/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
10/06/24 |
10/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
0
|
|
ASX - By Stock
|
SHP |
Re:
Ann: Ohmgebirge Scoping Study Conference Call Details
|
|
WelshBuffett
|
47 |
17K |
0 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
47
|
17K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
2 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
1 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
3
|
|
ASX - By Stock
|
SHP |
Re:
Ann: Ohmgebirge Scoping Study Conference Call Details
|
|
WelshBuffett
|
47 |
17K |
3 |
09/06/24 |
09/06/24 |
ASX - By Stock
|
47
|
17K
|
3
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
WelshBuffett
|
331 |
160K |
9 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
331
|
160K
|
9
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: AVZ Secures US$ 20 Million Funding Facility
|
|
WelshBuffett
|
331 |
160K |
1 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
331
|
160K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
WelshBuffett
|
13K |
6.4M |
7 |
08/06/24 |
08/06/24 |
ASX - By Stock
|
13K
|
6.4M
|
7
|
|